IONS

Ionis Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.61 1.77% 35.10 18:00:00
Open Price Low Price High Price Close Price Prev Close
35.18 33.88 35.80 35.10 34.49
more quote information »

Recent News

Date Time Source Heading
10/14/202116:06GLOBETopline Results from Tofersen Phase 3 Study and its Open..
9/30/202110:54DJNVC Daily: Expansion Therapeutics Gets $80 Million for..
9/23/202115:34SEEKPTC Therapeutics slips after early stage results from..
9/15/202107:30GLOBEBiogen Plans to Initiate Phase 3b Study Evaluating Potential..
9/03/202107:05PRNUSIonis to host ATTR symposium highlighting CARDIO-TTRansform..
9/02/202119:26EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:21EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202119:20EDGARStatement of Changes in Beneficial Ownership (4)
9/02/202107:05PRNUSIonis to present at upcoming virtual investor conferences
8/05/202117:00EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/04/202107:04SEEKIonis Pharmaceuticals EPS in-line, misses on revenue
8/04/202107:00PRNUSIonis reports second quarter 2021 financial results and..
8/02/202110:14SEEKIonis provides enrollment update for Novartis' late-stage..
8/02/202109:30PRNUSLp(a) HORIZON achieves 50% enrollment in trial to assess the..
7/29/202107:47SEEKIonis completes enrollment in late-stage eplontersen..
7/29/202107:05PRNUSIonis completes enrollment in pivotal NEURO-TTRansform study..
7/26/202117:01SEEKBiogen and Ionis post promising data from early-stage..
7/26/202116:35PRNUSBiogen and Ionis report positive topline clinical data on..
7/21/202107:05PRNUSIonis to hold second quarter 2021 financial results webcast
7/13/202107:27SEEKIonis inks licensing deal with Bicycle Therapeutics to..
7/13/202106:59PRNUSIonis enters exclusive licensing agreement with Bicycle..
7/06/202117:53EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:53EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:51EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:51EDGARStatement of Changes in Beneficial Ownership (4)
6/25/202117:20EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202117:05EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202118:46EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202116:05PRNUSIonis' Chief Scientific Officer C. Frank Bennett, Ph.D.,..
6/10/202118:05PRNUSIonis' antisense therapies in ATTR amyloidosis to be..
6/10/202108:48DJNBiogen: Research Supports Development of Investigational..
6/10/202107:30GLOBENew Data at Cure SMA 2021 Highlight the Long-Term Efficacy..
6/09/202119:02EDGARInitial Statement of Beneficial Ownership (3)
6/04/202116:44EDGARCurrent Report Filing (8-k)
6/02/202119:59PRNUSIonis announces changes to its board of directors at annual..
5/26/202107:05PRNUSIonis to present at upcoming investor conferences
5/20/202116:28EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/06/202107:05PRNUSIonis to present at upcoming investor conferences
5/05/202116:05PRNUSIonis to host 2021 virtual annual meeting of stockholders
5/05/202114:59EDGARQuarterly Report (10-q)
5/05/202111:16EDGARCurrent Report Filing (8-k)
5/05/202108:06SEEKIonis Pharma trails Q1 consensus; top-line off 16%
5/05/202107:02SEEKIonis Pharmaceuticals EPS misses by $0.09, misses on revenue
See more news about this stock »
Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211016 03:54:28